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CHARACTERIZING NEUROANATOMICAL CHANGES IN PARVALBUMIN 
AND PERINEURONAL NETS IN A RAT DISC-1 KNOCK OUT MODEL 
 
HA-NEUL LEE 
ABSTRACT  
BACKGROUND: Schizophrenia is a debilitating disorder that has a profound 
impact on quality of life due to the presence of both cognitive deficits and 
psychotic symptoms. Despite having significant global economic and social costs 
and a worldwide prevalence of 1%, schizophrenia is still not well understood. 
Research has been making strides in uncovering the pathophysiology and the 
etiology that drive this disease, ranging from genetic abnormalities, disrupted 
circuitry, changes in microarchitecture, to impaired synaptic connectivity.  
Evidence suggests that disrupted-in-schizophrenia-1 (DISC1) driven genetic 
disturbances in fast-spiking parvalbumin (PV) neurons and their surrounding 
perineuronal nets (PNNs) likely contribute to schizophrenia etiology as they are 
part of the microcircuits required for working memory, a cognitive function that 
has been consistently impaired in schizophrenic patients.  
OBJECTIVE: To identify the neuroanatomical changes in PV neurons and 
surrounding PNNs in the superficial and deep layers of the prelimbic and 
infralimbic prefrontal cortex of a rat DISC-1 knockout model.  
METHODS: 19 DISC1-KO male rats and 15 wildtype rats were treated with 
saline or MK-801. They were sacrificed between P268-269 and brains were 
		 vi 
extracted and separated at the corpus callosum. After fixing and preserving, the 
brains were sliced then stained to visualize parvalbumin and perineuronal nets 
with immunohistochemistry. Slices were imaged and analyzed for PV, PNN, and 
PV+PNN counts in the superficial and deep regions of the prelimbic and 
infralimbic cortices. Averages counts within each group were taken and analyzed 
via 2-way ANOVAs for each brain region and dependent variable. 
RESULTS: DISC1-KO rats displayed the following trending changes: decreased 
PV cells in deep layers of infralimbic and decreased PNNs throughout the 
prelimbic cortex. MK-801 appears to increase the number of unsheathed PV cells 
in the superficial layers of prelimbic and infralimbic cortex.  It decreased the 
number of PNNs in the prelimbic of wildtype animals but not in the DISC1-KO 
cohort. MK-801 moderately increased PV counts in DISC1-KO.  
CONCLUSIONS: This DISC1-KO model is a promising model of schizophrenia 
as we see the same directionality of decreases in PV and PNN as post mortem 
human studies. Furthermore, MK-801 is seen to have an increasing trend effect 
on PV cells, which should be considered when interpreting findings in future 
studies that look at these markers.   
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INTRODUCTION 
Schizophrenia 
 Schizophrenia is a complex psychiatric disorder that has an estimated 
prevalence rate of 0.5-1% worldwide (Bitanihirwe & Woo, 2014; Dienel & Lewis, 
2018; Najjar & Pearlman, 2015; Picchioni & Murray, 2007). It is characterized by 
the presence of symptoms broadly categorized into three categories: cognitive, 
positive and negative (Bitanihirwe & Woo, 2014; Meyer & Feldon, 2010; Patel, 
Cherian, Gohil, & Atkinson, 2014; Woo, 2014). Positive symptoms are defined as 
features that appear due to the disease process but are not normally present; 
this includes paranoia, delusions, and hallucinations (Meyer & Feldon, 2010; 
Woloszynowska-Fraser et al, 2017; Woo, 2014; Gejman et al., 2010). Negative 
symptoms are those that are should be present but are otherwise reduced or 
absent, which includes apathy, withdrawal, and a flattened affect (Gejman, 
Sanders, & Duan, 2010; Meyer & Feldon, 2010; Woo, 2014). Cognitive 
impairment spans broadly into executive functions, notably working memory and 
sustained attention. As these deficits are seen in 98% of schizophrenia patients 
(Keefe, Eesley, & Poe, 2005) and present long before psychosis onset (Dienel & 
Lewis, 2018; Heinrichs, 2005; Keefe et al., 2005; Tripathi, Kar, & Shukla, 2018; 
Woloszynowska-Fraser, Wulff, & Riedel, 2017), cognitive impairment is arguably 
the most pervasive and significant symptom type for this disease (Albus et al., 
2006; Bilder et al., 2000; Heinrichs, 2005). It persists even throughout medication 
and stabilization of psychotic symptoms (Bilder et al., 2000; Bowie & Harvey, 
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2006; Erlenmeyer-Kimling et al., 2000; Heinrichs, 2005; Hill, Schuepbach, 
Herbener, Keshavan, & Sweeney, 2004; Hoff et al., 1999). Furthermore, the 
extent of impairment is the most effective predictor of long-term functional 
outcomes and prognosis (Dienel & Lewis, 2018; M. F. Green, Kern, Braff, & 
Mintz, 2000; Michael F. Green, 2016; Kahn & Keefe, 2013). Currently, there are 
no effective treatments options for these cognitive impairments (Bowie & Harvey, 
2006; Goff, Hill, & Barch, 2011), which highlights the importance of 
understanding the neurobiological underpinnings of these deficits for future 
targeted treatments.  
Schizophrenic symptoms typically manifest in the late teens to mid 30s 
(American Psychiatric Association, 2013; Mueser & Jeste, 2008; Picchioni & 
Murray, 2007; Woo, 2014) with prodromal cognitive disturbances usually present 
long before the first psychotic episode (Dienel & Lewis, 2018; KANE & LENCZ, 
2008). The first signs of cognitive impairment can appear during early childhood 
and progress insidiously through the prodromal phase in adolescence (Kane & 
Lencz, 2008). These deficits are thought to be the result of aberrant processes 
during active neurodevelopment which culminates into a fully blown disease 
when the dysfunctional regions or circuits become mature or active (KANE & 
LENCZ, 2008; Marenco & Weinberger, 2000). This assumption is supported by 
the delayed maturation of the prefrontal cortex, an area strongly implicated in 
cognitive deficits associated with schizophrenia (Giedd, 2004; Gogtay et al., 
2004; Huttenlocher & Dabholkar, 1997; Marenco & Weinberger, 2000).  
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The delayed onset of the full manifestation of the disease is suggestive of 
neurodevelopmental origins. However, the precise etiology and pathophysiology 
has yet to be ascertained. It is largely understood that it has a multifactorial 
cause, which includes genetic (Buxbaum et al., 2008; Niendam et al., 2018; 
Saetre et al., 2008; Schumacher et al., 2009), social (Boydell et al., 2001; Veling 
et al., 2007) and environmental contributions (Dalman, Allebeck, Cullberg, 
Grunewald, & Köster, 1999; P. B. Jones, Rantakallio, Hartikainen, Isohanni, & 
Sipila, 1998; KANE & LENCZ, 2008; Marenco & Weinberger, 2000). It is thought 
that the interaction of multiple susceptibility genes and environmental factors 
leads to the manifestation of the disease (Maynard, Sikich, Lieberman, & 
LaMantia, 2001; Picchioni & Murray, 2007). The presence of a single vulnerability 
gene, such as disrupted in schizophrenia-1 (DISC1) (Jaaro-Peled, 2009; Saetre 
et al., 2008; Schumacher et al., 2009), does not necessarily equate to developing 
the clinical syndrome; however, it may confer a small susceptibility effect (Lewis 
& Levitt, 2002; Sanders et al., 2008) that can be additive with other vulnerability 
genes, like neuroregulin1 (NRG1), human dystrobrevin binding protein 1 
(DTNBP1), and nuclear distribution element like (NDE1) (Burdick et al., 2008; 
Kamiya et al., 2006; Lipska et al., 2006). Due to the multiple implicated factors 
and heterogeneity of the disease, it is plausible that the disease requires a two-
hit model (Bayer, Falkai, & Maier, 1999; Feigenson, Kusnecov, & Silverstein, 
2014). The initial hit, genetic or environmental, would disrupt an aspect of 
neurodevelopment, priming the underlying neurocircuitry to be vulnerable to a 
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second hit which will exacerbate the abnormal processes to yield the clinical 
disease (Maynard et al., 2001).  
Epidemiological and cohort studies provide further support for the 
neurodevelopmental origin theory – via disruption of typical neural development 
in utero – as associations between the prenatal exposure to infection and 
increased schizophrenia prevalence have been described (A. S. Brown et al., 
2000; Alan S. Brown, 2011; Alan S. Brown et al., 2004; Alan S. Brown & Derkits, 
2010). Interestingly, the prenatal period has been noted to be the most 
vulnerable to any epigenetic disruptions that could have long-lasting effects 
(Kundakovic & Jaric, 2017; Nestler, Peña, Kundakovic, Mitchell, & Akbarian, 
2016). However, not all cases of prenatal infections lead to developing 
schizophrenia, which suggests a second component or “hit” may be necessary.  
Monozygotic studies show that there is not a 100% concordance rate 
(Kendler & Robinette, 1983; Onstad, Skre, Torgersen, & Kringlen, 1991; Pepper, 
Pathmanathan, McIlrae, Rehman, & Cardno, 2018), indicating there is an 
interaction between genetics and environment. In a study that compared the 
rates of schizophrenia between adoptees of typical biological parents raised by 
schizophrenic parents and adoptees of schizophrenic biological parents raised by 
normal parents, the former group had an incidence rate of 18.8% and the latter 
had 10.7% (Wender, Rosenthal, Kety, Schulsinger, & Welner, 1974). This 
indicates that both genetics and environment are risk factors, but that genetics 
may confer greater risk (Roth, Lubin, Sodhi, & Kleinman, 2009).  
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Epigenetic changes in genes have been noted in schizophrenia (for a 
review, see (Roth et al., 2009; Teroganova, Girshkin, Suter, & Green, 2016). 
These observed changes are seen in DNA methylation (Abdolmaleky et al., 
2006; Liao et al., 2015) and histone modifications (Huang et al., 2007; Sharma, 
Grayson, & Gavin, 2008), both of which are influenced by environmental factors 
and are mechanisms that regulate gene expression (Liao et al., 2015). Some of 
the genes that exhibit differential methylation in schizophrenia, such as DISC1, 
are involved in neurodevelopment, further implicating aberrant processes in early 
development as a likely contributor to schizophrenia (Liao et al., 2015). In a study 
that profiled genome wide DNA methylation in the blood derived DNA of 
individuals carrying the chromosome 1 and 11 translocation and their family 
members that are non-carriers, it found 13 significant differentially methylated 
regions that surrounds the breakpoints of the translocation. Indeed, four of the 
regions were found to be mapped to the DISC1 gene (McCartney et al., 2018). 
The consequences of these epigenetic changes are seen in altered expression in 
genes that are implicated in prefrontal dysfunction related to GABAergic neurons, 
such as the decreased expression of glutamic acid decarboxylase 67 (GAD67), 
an enzyme that synthesizes GABA (Huang et al., 2007).  
Beyond the abnormalities in gene expression, there are overall gross 
neuroanatomical changes observed in the neuroanatomy of schizophrenic 
patients via imaging and post mortem studies. Previous evidence has indicated 
that patients that go on to develop schizophrenia have a greater prevalence of 
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physical anomalies that are indicative of an early life disruption in development 
(Alan S. Brown, 2011). Specifically, morphological analyses show an increased 
prevalence of cavum septum pellucidum (CSP), a neuroembryonic marker of 
incomplete closure of the septal leaflets (Alan S. Brown, 2011). Septal leaflets 
are an important indicator of normal fetal neurodevelopment and abnormalities 
can result in psychiatric disturbances such as psychosis (Li et al., 2011; 
Supprian, Sian, et al., 1999), which can be visualized through magnetic 
resonance scans. Additionally, magnetic resonance imaging (MRI) studies have 
shown a significant difference in the CSP between schizophrenia patients and 
normal controls (Beraldi et al., 2018; Degreef et al., 1992). Although its specific 
role in the disorder is unclear, a large CSP is considered to be a marker of 
abnormal development of the limbic system (Beraldi et al., 2018), a system that 
is thought to play a significant role in affective and cognitive symptoms seen in 
patient populations  (Nishijo, Rafal, & Tamietto, 2018; Rolls, 2015; Supprian, 
Heils, et al., 1999)  
Imaging studies on post-mortem brains of schizophrenic patients have 
revealed insight into abnormalities seen in various brain regions. These 
progressive structural changes in the brain were also identified via imaging in 
high-risk patients that are close relatives of a schizophrenic patients. A multi-site 
mega-analysis conducted by Rozycki et al. (2018) found robust group differences 
between healthy and schizophrenic patients in both positive and negative 
directions, in which the amygdala, hippocampus and prefrontal cortex was 
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smaller in schizophrenia and lateral third ventricle and pallidum were larger 
compared to healthy controls. Notably, there was an evident gray matter volume 
loss compared to healthy controls in the prefrontal cortex (PFC), temporal cortex, 
parietal cortex, insula, and amygdala, with the greatest deficit seen in the PFC 
(Goghari, MacDonald, & Sponheim, 2014; Karlsgodt, Sun, & Cannon, 2010; 
Rozycki et al., 2018).  These regional abnormalities are consistent with the 
observed symptoms in schizophrenia as they, the prefrontal cortex in particular, 
critically contribute to cognition (Goghari et al., 2014) and emotional processing 
(Glotzbach et al., 2011). Furthermore, the schizophrenic group was found to 
have significantly greater pallidum and ventricular volumes with considerable 
effect sizes (Rozycki et al., 2018).  These changes are hypothesized to be the 
cumulative result of changes in neuroplasticity, neuronal maturation, and an 
altered neurodevelopmental trajectory (Buckley, 2005; Karlsgodt et al., 2010; 
Meyer-Lindenberg & Tost, 2014; Tripathi et al., 2018). The agents of these 
neurodevelopmental and neuroplasticity changes are still being investigated; 
however, it is suspected that mutations in the DISC1 gene causes widespread 
changes that have downstream effects on the GABAergic neuron population, 
extracellular matrix integrity, and mitochondrial function, which in turn throws the 
normal neurodevelopmental course array (Norkett, Modi, & Kittler, 2017; Ye et 
al., 2017).  
A bevy of evidence implicates abnormalities in the PFC as part of the 
pathophysiology of schizophrenia. Imaging studies utilizing positron emission 
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tomography (PET) and single photon emission computed tomography (SPECT) 
saw decreased blood flow and metabolism in the PFC of schizophrenic patients 
performing a cognitive task, indicating prefrontal dysfunction (Andreasen et al., 
1992; Goldman-Rakic & Selemon, 1997; Kawasaki et al., 1993; Liddle et al., 
1992). The PFC has been noted to be an integral component of working memory 
and dysfunctions in this area align with the canonical deficits seen in working 
memory tasks of schizophrenics.  Furthermore, studies show increases in the 
neuronal density of the PFC, specifically in the dorsolateral PFC (DLPFC), 
alongside a reduction in cortical thickness (Francine M. Benes, McSparren, Bird, 
SanGiovanni, & Vincent, 1991; Goldman-Rakic & Selemon, 1997; Selemon, 
2004; Selemon, Rajkowska, & Goldman-Rakic, 1998). Increased densities were 
especially noted in cortical layers 2, 3, 4 and 6, with no observable changes in 
the neuronal count (Goldman-Rakic & Selemon, 1997; Selemon, 2004; Selemon 
et al., 1998). This suggests there is actually a decrease in neuropil, a network of 
cell processes and synapses. A loss of neuropil may confer a loss of terminals 
and changes in the synaptic stability and maintenance, which may lead to 
impaired connectivity (E. G. Jones, 1997).  
Additional studies also have shown consistent changes to the GABAergic 
neurotransmission in the PFC with associated decreases in expression of 
GAD67 mRNA and protein (Dienel & Lewis, 2018; Woo, 2014). The GABAergic 
system plays an important role in the inhibition of the excitatory pyramidal cells 
throughout the brain. Its dysfunction can lead to an imbalance in excitation and 
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inhibition (Voineskos, Rogasch, Rajji, Fitzgerald, & Daskalakis, 2013), and this 
balance is considered necessary for normal executive processes. This suggests 
that GABA plays a pivotal role in producing the cognitive deficits seen in 
schizophrenia. Furthermore, there has been evidence of hypofunction at the 
NMDA receptor (Voineskos et al., 2013), which has influence over GABA 
interneuron firing (Woo, 2014). Studies have also shown evidence of lower 
gamma oscillatory power in the PFC of schizophrenic patients when compared to 
healthy controls. The gamma frequency of oscillations has been associated with 
working memory function, in which the power of oscillations increases with more 
demanding cognitive tasks. Mounting evidence shows that parvalbumin (PV), a 
protein expressed on a subset of GABAergic interneurons, contributes to the 
generation of these network oscillations, which are also coupled with the 
inhibitory activity. Post mortem studies show a well characterized, marked 
decrease in PV interneurons in the hippocampus and medial PFC (mPFC; Lewis, 
Hashimoto, & Volk, 2005). It has been hypothesized that the observed 
dysfunction in these inhibitory mechanisms may be downstream effects of a 
genetic mutation.   
While there have been strides in our understanding of the development of 
schizophrenia, there is a lack of consistency in the findings as not all patients 
have the same presumed etiological cause. Despite these inconsistencies, there 
are certain genes that have been identified that seem to increase the risk of 
developing schizophrenia significantly. Thus, elucidating the impact of these 
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genes on neurodevelopment will only serve to uncover the factors that drive the 
disease. 
Disrupted in Schizophrenia 1 (DISC1) 
 DISC1 is considered a strong candidate susceptibility gene for 
schizophrenia and other psychiatric disorders, like bipolar affective disorder, and 
recurrent major depression (Brandon et al., 2009; Pletnikov et al., 2008). The 
DISC1 gene was first identified through a study in a large Scottish family with a 
high penetrance of the translocation between chromosomes 1 and 11, which was 
found to co-segregate with the psychiatric disorders listed previously (Brandon et 
al., 2009; Norkett et al., 2017; Pletnikov et al., 2008). Inheritance of this 
translocation could confer a 50-fold increased risk compared to the general 
population (Brandon et al., 2009; Norkett et al., 2017). The DISC1 gene, which 
encodes for the DISC1 protein that has a large globular N-terminus, a self-
association domain and a coiled coil rich C-terminus, was discovered on 
chromosome 1 when analyzing the interrupted regions from the translocation 
(Brandon et al., 2009; Norkett et al., 2017). There are three hypothesized effects 
of the translocation: abnormal transcripts encoding DISC1 1-597 and 60 to 69 
new amino acids from chromosome 11, a truncated DISC1 transcript ending at a 
breakpoint, or haploinsufficiency due to no expression of the abnormal transcript 
(Norkett et al., 2017; Pletnikov et al., 2008).  
 DISC1 has been identified as a key player in the regulation of neuronal 
processes during development, such as growth (Kamiya et al., 2005), expansion 
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and migration (Kim et al., 2009; Tripathi et al., 2018; Wu et al., 2017). Research 
also shows its role is much more widespread as it is a key regulator of cortical 
neuronal precursor cell (NPC) proliferation, neuronal differentiation, mitochondrial 
homeostasis, intracellular trafficking, and intracellular signaling (Burdick et al., 
2008; Deng et al., 2017; Mao et al., 2009; Norkett et al., 2017; Pletnikov et al., 
2008). Its broad range of functions is likely due to the fact DISC1 can have over 
100 potential interaction partners, such as kinesin motor proteins, Lis1, Nde1, 
phosphodiesterases, and mitochondrial proteins (Norkett et al., 2017). Primarily, 
the DISC1 protein is known to act as a scaffolding protein that assists with 
protein complex formations through its multiple motifs (Pletnikov et al., 2008). 
The truncated form of the protein could result in the loss of interactions with 
these binding partners, which may lead to aberrant systems that ultimately 
results in schizophrenia like symptoms (Morris, Kandpal, Ma, & Austin, 2003).  
 Beyond its role in ATP production, DISC1 is thought to contribute to 
mitochondrial calcium buffering since knockdown models have shown increased 
time in returning to baseline intramitochondrial calcium levels (Norkett et al., 
2017). The symptoms of schizophrenia could be secondary to impaired ATP 
production, calcium buffering, and decreased dendritic outgrowth from altered 
regulation. These molecular abnormalities may impair network connectivity, 
which could contribute to the onset of schizophrenia (Norkett et al., 2017). Due to 
its interaction with proteins involved in neurodevelopment and neurosignaling, 
DISC1 is hypothesized to be a critical hub protein that exists as the junction for 
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major proteins involved in normal brain development (Ye et al., 2017).  Beyond 
the knowledge of Ndel1/Nde1 being a modulatory component of the dynein 
complex and having a role in regulating brain development through cell cycle 
control, not much is known about the exact functions behind its interaction with 
DISC1. However, it has been noted that Ndel1 has been associated with DISC1 
in psychiatric disorders and the complete removal of Ndel1 in mice has been 
found to be embryonically lethal. Furthermore, it has been found that the c-
terminal of DISC1 is necessary for Ndel1/Nde1 binding (Brandon et al., 2009). 
When the 1, 11 balanced translocation mutation truncates this terminal by 
deleting residues 598 to 854 and disrupting its binding to Ndel1/NDe1, 
microcephaly was observed in both mice and humans (Alkuraya et al., 2011). 
This indicates the relevance of the DISC1/Ndel1/Nde1 interaction for normal 
development. However, all are scaffolding proteins capable of interacting with 
several other components, rendering it difficult to make clear interpretations of 
their roles.  
In the experiments conducted by Ye et al., DISC1 was found to regulate 
neurogenesis through its connections with Ndel1/Nde1. Interruptions of the 
DISC1/Ndel1 interaction resulted in mitotic delays due to difficulty of the 
chromatids to separate after metaphase. Presumably, this is due to Ndel1’s role 
in recruiting the dynein complex, which includes centrosomes and kinetochores, 
to the necessary machinery in the cell cycle. DISC1 is assumed to regulate 
Ndel1’s kinetochore localization, a necessary event for anaphase, and thus 
	13 
influence cell cycle progression.  Disruptions in this interaction were found to 
cause delayed cell cycle progression and reduced proliferation of these neural 
stem cells in the ventricular zone of the cortex. Due to its role in cognition and 
emotional processing, impaired neurogenesis in the cortex seems to be a 
promising contributor to the symptoms of schizophrenia (Burdick et al., 2008; Ye 
et al., 2017). This suggests DISC1 may have a role in schizophrenia 
pathophysiology through the disruption in interaction with NDEl1/NDe1.  
 Neuroplasticity is an important process for development and maturation as 
it is the ability of a circuit to respond to experience and learning. Altered 
neuroplasticity is thought to be a potential driver behind cognitive deficits. Studies 
have suggested a possible role of DISC1 in neuroplasticity due to its localization 
at the synapse. In postmortem imaging studies, a reduction in dendritic spine 
density on cortical pyramidal neurons has been consistently observed (Garey et 
al., 1998; Glantz & Lewis, 2000; Rosoklija et al., 2000). The excitatory 
postsynaptic compartments are found in the dendritic spines and the spines’ 
morphology has been associated with synaptic plasticity and neuronal activation 
(Yuste & Bonhoeffer, 2001). In support of this theory, truncated DISC1 gene 
mouse models found a significant decrease in synaptic spines in the dentate 
gyrus with corresponding impairment in working memory (Brandon et al., 2009; 
Glausier & Lewis, 2013; Mao et al., 2009). The exact mechanisms of how DISC1 
regulates the actin cytoskeleton, a component critical for spine formation and 
neuroplasticity, is largely unknown. It is suspected it may be through its 
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interactions with kalirin-7 (Kal-7), a rac1-GTP exchange factor and a unit of 
synaptic signaling pathways, and Traf-and nck-interacting kinase (TNIK), a 
kinase linked to actin cytoskeleton regulation (Tropea, Hardingham, Millar, & Fox, 
2018). Kal-7 has been found to be decreased in schizophrenia and TNIK has 
been linked to the impaired cortical function observed in the disease (Coba et al., 
2012; MacLaren, Charlesworth, Coba, & Grant, 2011).  
Parvalbumin 
 Parvalbumin (PV) is a calcium binding protein that is selectively expressed 
on GABAergic neurons within the brain (Caroni, 2015; Dienel & Lewis, 2018). 
There are two main subtypes of PV-expressing cells and are named based on 
their projection targets: PV basket cells and PV chandelier cells. The chandelier 
cells target the axon initial segment of the pyramidal cells and has a slower 
inhibitory postsynaptic current (IPSC) decay than the basket cells (Dienel & 
Lewis, 2018). PV-containing basket cells target the perisomatic region of 
pyramidal cells, which consists of the cell body, proximal dendrites and initial 
axon segment, and are characterized by their fast-spiking properties with rapid 
IPSC decay (Dienel & Lewis, 2018; Galarreta & Hestrin, 2002). This fast spiking 
phenotype serves to drive the gamma oscillatory activity, which is thought to 
coordinate large ensembles of neuronal activity that is necessary for memory and 
cognitive processes (Dienel & Lewis, 2018; Kim et al., 2016; Veres, Nagy, & 
Hájos, 2017.). Mounting evidence suggests that these PV+ interneurons play a 
critical role in working memory function through regulating the synchronization of 
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large ensembles of principal neurons firing for specific brain states and 
generating network oscillations necessary for higher order cognition (Kim et al., 
2016, 2016; Veres et al., 2017.). This synchronization allows for efficiency in 
neural processing for local networks of neurons. Its presence is required for 
normal brain activity since its dysfunction has been seen to result in impaired 
higher order processing (Haenschel et al., 2009; Kucewicz et al., 2014; Williams 
& Boksa, 2010). For this reason and others, aberrations in PV interneurons have 
long been considered putative targets of dysfunction in schizophrenia research.  
 Gamma frequency of oscillations in the PFC has been associated with 
working memory function, in which the power of the oscillations corresponds to 
the cognitive load (Dienel & Lewis, 2018). In schizophrenia, there has been 
evidence of lower gamma oscillatory power in relation to the demands of the 
cognitive task (Dienel & Lewis, 2018). Interestingly, changes in PV interneurons 
function and distribution in the PFC has been seen in postmortem pathology, 
which further supports the role of PV cell dysfunction in the maintenance of 
working memory processes through its influence over gamma frequency (Lewis 
et al., 2012; Murray et al., 2015).  
 Consistently, changes to GABAergic neurotransmission in the PFC has 
been seen in postmortem tissue of schizophrenia with associated lower levels of 
GAD67 mRNA and protein (Dienel & Lewis, 2018; Woo, 2014). GAD67 is 
significant since it synthesizes most of the cytosolic GABA (Egerton, Modinos, 
Ferrera, & McGuire, 2017). Furthermore, GAD67 and PV are activity dependent 
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gene products in which greater activity reflects greater expression (Hensch, 
2005). The decrease in GAD67 is presumed to confer a weakened inhibition on 
the PV basket cells (Dienel & Lewis, 2018).  
 Evidence shows that decreased inhibition from the PV basket cells is 
driven by the hypofunction of NMDA receptors on these cells, as less GABA 
synthesis is detected (Voineskos et al., 2013; Woo, 2014). NMDA hypofunction 
has long been implicated in the cognitive symptoms of schizophrenia, as the 
balance between excitatory and inhibitory neurotransmission appears to be 
mediated through its activity (Voineskos et al., 2013). Antagonizing the receptor 
was found to prevent the GABA interneurons from firing so the pyramidal 
neurons are no longer inhibited, resulting in an imbalance in excitation and 
inhibition (Voineskos et al., 2013). This balance was found to be necessary for 
executive processes, suggesting NMDA hypofunction is part of the 
pathophysiology of schizophrenia (Voineskos et al., 2013).  
  Although evidence suggesting alterations of NMDA receptors in 
schizophrenic subjects have been mixed, rodent studies have found reduced 
frequency and amplitudes of the miniature IPSC after administration of ketamine, 
a NMDA receptor antagonist (Mathew & Hablitz, 2011). Furthermore, the ablation 
of the NR1 subunit of the receptor in preadolescent mice were found to result in 
spatial working memory deficits and lower expression of GAD67 and PV in 
adulthood (Woo, 2014). These findings imply that impaired signaling through 
NDMA receptors on PV cells, either through deficit of its subunits or its 
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antagonism, has downstream effects of decreasing GAD67 and PV expression 
and thus, may lead to dysfunction in gamma oscillations and working memory 
(Dienel & Lewis, 2018; Woo, 2014). And lending support to the developmental 
theory of schizophrenia, NMDA receptor antagonism was found to produce 
deficits in PV and GAD67 only during prepuberty but not post-puberty (Woo, 
2014).  
Low doses of non-competitive NMDAR antagonists were found to induce 
positive, negative and cognitive symptoms of schizophrenia in healthy subjects 
(Krystal et al., 1994) and reintroduce these symptoms in stabilized 
schizophrenics (Lahti, Koffel, LaPorte, & Tamminga, 1995). Rodent studies that 
ablate or decrease expression of NMDAR subunits such as NR1 subunit were 
found to produce similar deficits in behavior (Belforte et al., 2010; Duncan et al., 
2004). It was found that NMDAR antagonists may preferentially target cortical 
GABAergic cells since findings show acute administration results in hyperactivity 
of pyramidal cells (Jackson, Homayoun, & Moghaddam, 2004; Suzuki, Jodo, 
Takeuchi, Niwa, & Kayama, 2002) with an overall net hyperactivity in the brain 
(Miyamoto, Leipzig, Lieberman, & Duncan, 2000). Likewise, chronic 
administration was found to decrease expression of both PV and GAD67 in the 
cortex (Cochran et al., 2003; Keilhoff, Becker, Grecksch, Wolf, & Bernstein, 
2004; Morrow, Elsworth, & Roth, 2007), which substantiates claims that NMDAR 
hypofunction is linked to PV cell dysfunction. The observed decrease in cortical 
inhibition in schizophrenic patients is suggestive of the vulnerable nature of PV 
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cells (Daskalakis et al., 2002; Wobrock et al., 2008). This decrease is presumed 
likely to be due to the dysfunction in the neurons itself (Nakazawa et al., 2012). It 
is reasonable to believe PV cells are susceptible to NMDAR hypofunction as they 
have develop over an extensive period of time, which allows any disruptions to 
have profound impacts on their development (Nakazawa et al., 2012). This 
makes it a compelling source to study in schizophrenia since cortical PV cell 
disruption has been associated with other mental disorders such as major 
depressive disorder (F. M. Benes & Berretta, 2001). Furthermore, the 
hypofunction of NMDAR on PV neurons was found to disrupt the gamma 
frequency synchrony, the basis for higher order cognitive function, which was 
found to be disrupted in human studies.  
Perineuronal Nets 
 Perineuronal nets (PNNs) are reticular structures that are comprised of 
condensed components of the extracellular matrix (ECM) including 
proteoglycans, hyaluronan, and chondroitin sulfate that interact to form a lattice-
like structure around the soma, dendrites, and axons of mature neurons (F. M. 
Benes & Berretta, 2001). Due to its appearance at the end of the critical period, it 
is assumed that the PNNs stabilize the synapses and the mature neural network 
by restricting neuroplasticity (Lensjø, Lepperød, Dick, Hafting, & Fyhn, 2017; 
Pantazopoulos, Woo, Lim, Lange, & Berretta, 2010; Paylor et al., 2018; Tsien, 
2013). Furthermore, the density of PNNs has been observed to increase with 
age, suggesting the formation of these structures are experience or activity 
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dependent (Hensch, 2005). They are found widely distributed throughout the 
brain—in the entorhinal cortex, prefrontal cortex, hippocampus, and amygdala 
(Bitanihirwe & Woo, 2014) and preferentially surrounds fast spiking PV neurons 
(N. P. Morris & Henderson, 2000). It is important to note that PNNs are dynamic 
in their form, and can reorganize and remodel in response to synaptic plasticity  
(Berretta, Pantazopoulos, Markota, Brown, & Batzianouli, 2015).  
PNNs are thought to be critical structures in regulating synaptic plasticity 
(Thompson et al., 2018) and the development and neuroprotection of the central 
nervous system (CNS); processes all found to be dysfunctional in schizophrenia 
(Bitanihirwe & Woo, 2014; Paylor et al., 2018). PNN expression increases as the 
brain is approaching the period of network stability and the end of heightened 
plasticity, which coincides with the end of adolescence (Paylor et al., 2018). 
Interestingly, PNNs have been found to be decreased in the PFC, amygdala, 
superior temporal cortex and entorhinal cortex in post mortem tissues of 
schizophrenic patients (Berretta et al., 2015; Bitanihirwe & Woo, 2014; Enwright 
et al., 2016; Mauney et al., 2013; Pantazopoulos et al., 2010; Paylor et al., 2018). 
Furthermore, these findings corresponded with cognitive impairments when 
replicated in animal models (Paylor et al., 2016, 2018; P. Steullet et al., 2017).   
Due to its polyanionic nature, PNNs are assumed to be involved in 
maintaining ion homeostasis in the local environments around metabolically 
active neurons like fast spiking PV interneurons (Bitanihirwe & Woo, 2014). Since 
the ECM establishes the local Cl- concentration, a disruption in PNNs could alter 
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the amount of inhibition a pyramidal cell receives from the PV interneurons; this 
PV-pyramidal cell circuit is thought to key for gamma oscillatory activities 
generated for cognitive tasks (Enwright et al., 2016). There has been evidence of 
dysregulation of the antioxidant systems and increased amount of oxidative 
stress in schizophrenia (Do et al., 2000; Flatow, Buckley, & Miller, 2013; Yao, 
Leonard, & Reddy, 2006). PV cells have been shown to be especially vulnerable 
to damage from this type of stress (Hasenstaub, Otte, Callaway, & Sejnowski, 
2010; Inan et al., 2016; Kann, Papageorgiou, & Draguhn, 2014), but are usually 
protected by the PNNs from this damage (Bitanihirwe & Woo, 2014; Cabungcal 
et al., 2013; Enwright et al., 2016; Morishita, Cabungcal, Chen, Do, & Hensch, 
2015).  
The relationship between PNN and PV and its importance in producing the 
cognitive symptoms of schizophrenia is compelling. PNN formation has  been 
seen to be concurrent with PV neuron and inhibitory neural network maturation, 
which further implicates its relevance in memory and learning (Bitanihirwe & 
Woo, 2014). And since the firing properties of PV neurons largely establish 
normal gamma oscillations, deficits in PNNs are suggested to contribute to 
abnormal oscillatory activity (Pascal Steullet, Cabungcal, Cuénod, & Do, 2014) 
and thus altered cognition (Bitanihirwe & Woo, 2014). Furthermore, there is 
evidence that a loss of PNNs in the hippocampus corresponded with increased 
dopaminergic activity and increased firing rate of pyramidal cells, producing an 
overall hyperexcitability in the brain. These conditions make the hippocampus 
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susceptibility to dopamine hyperfunction, which is thought to be the source 
behind the positive symptoms of schizophrenia (Bitanihirwe & Woo, 2014).  
Beyond PV protection, PNNs were also found to regulate PV function 
(Bernard & Prochiantz, 2016; Cabungcal et al., 2013a, 2013b), specifically the 
PV cells’ excitability (Balmer, 2016; Lensjø et al., 2017) and dopamine signaling. 
Influence over these properties allows the PNNs to exert influence over network 
oscillatory activity (Pascal Steullet et al., 2014). Therefore, PNN dysfunction may 
be driving the network dysfunction seen in schizophrenia (Berretta, 2012; 
Berretta et al., 2015). This would corroborate the past findings suggesting that 
disturbed GABAergic signaling from decreased PV and GABA markers contribute 
to the cognitive impairment-related schizophrenic symptoms (Hashimoto et al., 
2008; Takanori Hashimoto et al., 2003; Huang et al., 2007; Volk, Austin, Pierri, 
Sampson, & Lewis, 2000). Altered neurodevelopment after PNN reorganization 
further implicates its role in the pathophysiology of the disease (Dityatev et al., 
2007; Lensjø et al., 2017; Liu et al., 2013; Pizzorusso et al., 2002). Studies found 
that the proteolysis of PNNs can create an environment that is optimal for 
synaptic plasticity, which may lead to instability in the extracellular matrix 
(Murase, Lantz, & Quinlan, 2017; Wen, Afroz, et al., 2018; Wen, Binder, Ethell, & 
Razak, 2018) and the rewiring of the networks (Pollock, Everest, Brown, & 
Poulter, 2014), all of which can lead to abnormal development from network 
dysfunction. Likewise, disruption in these structures were found to reopen these 
critical periods of plasticity which can cause destabilized synapses and thus 
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compromised neural circuits (Lensjø et al., 2017; Paylor et al., 2018). The 
dysfunction of neural circuitry seen after PNN dysfunction may be mediated by 
the reduced inhibition from PV cells and thus altered balance between the 
inhibitory and excitatory activities (Lensjø et al., 2017). 
These findings can be synthesized together to highlight the importance of 
both PNNs and PVs in the pathophysiology of schizophrenia. Due to the body of 
evidence supporting the notion that PNNs are developmentally regulated and 
activity dependent (Hensch, 2005), they appear towards the end of the critical 
period, and the closure of synaptic plasticity is necessary for proper network 
function, it provides substantial support that PNNs are necessary for typical 
neurodevelopment. Additionally, with the wealth of research provided on DISC1 
and its role in neurodevelopment, there seems to be support that DISC1 may be 
driving both the dysfunction seen in inhibitory circuits and abnormalities in PNNs. 
Therefore, the present work utilizes a novel DISC1-KO model to see if DISC1 
dysfunction precedes the loss of PV and PNNs seen in schizophrenia 
postmortem tissue and animal models.  
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SPECIFIC AIMS 
 
Due to observed prefrontal disruptions in a subset schizophrenic 
population with a DISC1 gene disruption, we are attempting to characterize the 
neuroanatomical changes in a novel rat DISC1-KO model to see the if this model 
can replicate the neuroanatomical findings seen in schizophrenia, and whether it 
can serve as a more translational model for future schizophrenia research. Since 
DISC1 has been implicated in being critical for typical neurodevelopment, and 
schizophrenia is purported to have neurodevelopmental origins, we hypothesize 
that a complete knock out of this gene will produce marked abnormalities within 
the PFC evidenced by decreased expression of PV and PNNs, both of which are 
critical for higher-order cognitive functioning. We anticipate the addition of MK-
801 to the knock out will produce an effective later-life challenge akin to the 
diathesis-stress model, and elicit even more drastic deficits, as it will further 
antagonize the NMDA receptors on the PV cells and produce greater dysfunction 
in these cells.  
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METHODS  
All animal procedures were reviewed and approved by Colby College’s 
Institutional Animal Care and Use Committee and conducted in accordance with 
federally regulated standards. 
Animals 
  Typical and transgenic Sprague-Dawley rats (Horizon Discovery) were 
acquired to serve as breeders and included three wild-type (WT) males, three 
WT females, three males with biallelic deletion within the DISC1 gene (DISC1-
KO), and three DISC1-KO females. All breeders were postnatal day (P) 48 upon 
arrival. Females and males of the same genotype were paired together for 
breeding on P122. Males were removed after 7 days, after which pregnant dams 
were left undisturbed in their cages until the birth of their litters. The following day 
(P1), the pups were toe-clipped for genotype identification and cross-fostered to 
evenly distribute sex and genotypes amongst the WT and HOM moms, such that 
all litters were mixed genotypes. Pups were weaned on P24 and pair-housed in 
same-sex pairs in individually ventilated, clear polycarbonate caging in a 
temperature and humidity-controlled vivarium with access to food and water ad 
libitum. A total thirty-four genotyped male pups were utilized for the present study 
and group breakdown was as follows: DISC1-KO (n=19) and WT (n=15).  
Dizocilpine Injections 
 Rats in each gene group were randomly assigned to treatment groups of 
either injections of 0.3mg/kg of dizocilpine (MK-801; Sigma-Aldrich) or saline. All 
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rats in the MK-801 groups were administered intraperitoneal injections on testing 
days (P45, P97-P101, P102, P121-126, P152, P165-166, P186-189, P192-196, 
P207-208, P234, and P240-242). No crossover treatments occurred between 
groups. See figure 1A for details on dosing schedule.   
Behavioral Assays 
 A battery of tests was conducted on the rats across behavioral testing 
paradigms and prior to euthanasia to assess the role of genotype and NMDA 
antagonist administration on subsequent behavior.  These behavioral assays 
included: social interaction, two pre-pulse inhibition (PPI) tests, Morris Water 
Maze to assess both special and working memory, novel place preference (NPP) 
test, and three novel object preference (NOP) tests. Social interaction/play 
habituation occurred on P35 and tested on P39. PPI habituation occurred on 
P42, assessed on P44, and tested the first time on P42 and again on P102 after 
5 days of sub-chronic MK-801 injections. Spatial memory test #1 was conducted 
from P121 to P126.  The 3 days of the first NOP habituation were from P149 to 
P151 and testing occurred on P152. A second NOP test and a NPP test was 
conducted on P165 and P166, respectively. Working memory tests began from 
P186 to P208 with a 26-day break and resumed from P234 to P242. NOP #3 and 
spatial memory test #2 were conducted only on the saline group. NOP #3 
habituation occurred from P248 to 249, then tested on P250. Spatial memory test 
#2 took place from P252 to P255, P263 and P268. Refer to Figure 1A for 
comprehensive methodological timeline. 
	26 
Brain Tissue Collection 
 Rat brains were obtained through rapid decapitation and immediate 
extraction for all groups from P268 to P269. The brains were sectioned into 
separate hemispheres at the corpus callosum and separately fixed and stored in 
4% paraformaldehyde solution (in phosphate buffer (PB); pH= 7.3-7.4) for three 
weeks of post-fixation before being transferred to 0.1% sodium-azide solution for 
long term storage until ready for sectioning. All brains were transferred into 30% 
sucrose solution in 0.1M phosphate buffer saline (PBS) for cryoprotection for 4 
days or until they sank, whichever came first, and then sliced with a freezing 
microtome (Leica, Buffalo Grove, IL) into 40μm coronal sections. Six series of 
sections of the PFC were stored free-floating in freezing solution at -20°C until 
processed for immunohistochemistry analyses.  
Immunohistochemistry 
 One series of tissue slices per brain were randomly selected to stain for 
PV and PNNs, and all sections were spaced approximately 240μm from one 
another. Free-floating sections were first washed (2x5min) in PBS then blocked 
with 5% normal donkey serum (NDS; Jackson ImmunoResearch, West Grove, 
PA) with 0.3% triton-X in PBS solution (PBST) and 1% bovine serum albumin 
(BSA; ThermoFisher Scientific) for 1 hour on an agitator at room temperature. 
The slices were then incubated in primary antibody solution: biotin conjugate 
Lectin from wisteria floribunda agglutinin (WFA; 1:000, Sigma; for visualization of 
PNNs), and anti-parvalbumin (raised in rabbit, 1:10,000, ThermoFisher; for 
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visualization of PV) in 0.3% PBST for two nights at 4°C on an agitator. After the 
primary incubation period, slices were rinsed 3 times in 5-minute increments in 
0.3% PBST and transferred into secondary antibody solution consisting of 0.3% 
PBST, streptavidin conjugate 488 (1:3000, ThermoFisher) which tags WFA, and 
donkey anti-rabbit secondary antibody Alexa 594 (1:500, abcam), to visualize 
PV. After incubating for 3 hours on an agitator at room temperature, sections 
were washed 3 times for 5 minutes in PBS. Hemisphere sections were mounted 
onto glass slides and dried before being cover-slipped with ProLong Gold 
antifade mounting medium (Invitrogen).   
Imaging 
 A Keyence All-in-One Fluorescence Microscope BZ-X710 was used to 
image the stained sections of the PFC. The slices of each brain were visualized 
at 4x magnification to select 4 to 5 slices for inclusion (approximately between 
3.72mm to 2.28mm relative to Bregma) and all photomicrographs used for 
analyses were taken at 20x magnification. Images of the superficial (cortical 
layers 1-3) and deep layers (cortical layers 4-6) of both prelimbic (PL) and 
infralimbic (IL) regions of the PFC, guided by the rat brain atlas (Swanson, 2004), 
were taken at 20x under both red (PV) and green (PNN) fluorescence (see 
photomicrograph locations in Figure 2B). 3 pictures were taken per slice per 
fluorescent channel: 1 superficial PL (20x), 1 deep PL (20x), 1 IL (20x), for a total 
of 6 pictures per slice. With each brain having 4 to 5 selected slices, 24-30 
images were taken in total for each brain and stored for later analysis via ImageJ.  
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Superficial and deep layers of the PL were determined on the microscope 
and side by side images were taken. Caution was taken to ensure no cells were 
double counted in these images by leaving small gap between the two collected 
images.  Because all layers of the IL can be visualized in one image under 20x, 
only one photo was taken. The superficial and deep layers of IL were later 
determined by editing in a line down the middle of the photo, separating it into 
right (superficial) and left (deep) regions for the brains with the midline on the left 
and the opposite for when the midline is on the right. See Figure 2B. 
  Each photomicrograph was analyzed using ImageJ software (NIH) for PV 
and PNN quantification. PV cells and PNNs in the superficial and deep regions of 
the IL and PL were counted using the multi-point tool. The number of PV cells 
surrounded by PNNs was measured by overlaying both PV and PNN images and 
counting the PV cells that are surrounded by PNNs. PV cells and PNNs that had 
distinct edges and fluoresced enough to distinguish from background were 
counted. In order to ensure accurate and reproducible counting, all images were 
taken at the same fluorescent intensity/exposure during microscopy.  
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Figure 1. Methodological Timeline. 
The rats undergone extensive behavioral 
training that spanned across their lifetime. 
Social interaction/play 
(SI/P); Habituation (Hab); pre-pulse inhibition 
(PPI); novel object preference (NOP); 
novel place preference (NPP); spatial memory 
(SpM); working memory (WM). 
Treatments (either 0.3mg/kg MK-801 or saline) 
were administered on acutely on test 
days and sub-chronically once for 5 
consecutive days. 
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Figure 2. Experimental Methods: (A) Regions that were sampled included the 
superficial PL(sPL), deep PL (dPL), superficial IL (sIL), and deep IL (dIL). The 
anatomical measurement is relative to Bregma. An example of the division of 
superficial and deep layers of the IL in a 20x photomicrograph is shown in (B). 
The two regions were divided by drawing a line at the midline. A representative 
example of a counted PV cell is shown in (C). A representative example of a 
counted PNN is shown in (D). A representative example of a counted PV cell 
surrounded by a PNN is shown in (E).  
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Statistical Analyses 
 To look for differences in the seven measures listed below within the 
regions of interest, we took the average number of PV cells and PNNs in the 
superficial, deep and total (superficial + deep for each region) regions of the PL 
and IL across all the slices for each brain and calculated group means. A Grubb’s 
outlier test (Grubbs, 1969) was conducted to remove any outstanding outliers. A 
two-way ANOVA [Treatment (Saline, MK-801) x Genotype (Con, DISC1-KO)] 
was conducted for each of the variables of interest-- number of PV cells without 
PNNs, total number of PV cells, total number of PNNs, % of PNNs that surrounds 
a PV cell, and % of PV cells surrounded by PNNs--to determine if there were any 
differences due to genotype and/or treatment.  In the event of a main effect or 
interaction, Holm-Sidak’s post-hoc analyses were conducted with corrections for 
multiple comparisons.  
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RESULTS 
Prelimbic Cortex Findings 
 
 Treatment by gene interaction influences total number of PNNs within the 
PL. There was a trending interaction observed (F (1,28) = 3.274; p = 0.081) 
across the total PL. This is evidenced in that within saline treatment group, 
DISC1-KO saw a modest decrease in the number of PNNs compared to WT. In 
the DISC1-KO group, MK-801 treatment appeared to increase PNN count 
compared to the WT group with the same treatment. No observable difference in 
PNN counts were seen specifically within the superficial or deep regions of PL, 
regardless of treatment or gene. See figure 3 for graphical data and figure 4 for 
representative photomicrographs.   
 
Figure 3. A trending interaction of treatment and gene on the number of PNNs 
was seen across the total PL (‡ p =0.081). DISC1-KO group saw a modest 
‡
‡ p = 0.081
Drug and Gene interaction on PNN countTreatment and Gene Interaction on PNN count
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decrease in PNNs compared to WT when given saline. Likewise, there is a slight, 
but appreciable decrease in number of PNNs in WT group when given MK-801 
compared to saline. However, there is a subtle yet observable increase in PNNs 
when given MK-801 in the DISC1-KO group. 
 
	
 
Figure 4. Representative photomicrographs of sampled regions in the PL that 
were analyzed for PNNs: superficial PL, deep PL, and total (superficial + deep 
combined) PL. The total PL photos were taken at a lower magnification (10x) to 
capture the entire region (A,D,G,J). A slight decrease in number of PNNs is seen 
in WT when treated with MK-801.  
 
	34 
 Gene dependent increase in the number of PV cells without PNNs in 
superficial PL. While genotype did not significantly alter the number of PV cells 
without PNNs across all regions of the PL (p > 0.05), there was an observable 
trend towards an increase in the count of PV cells without PNNs in the superficial 
layers (F (1,29) = 3.463; p = 0.072). DISC1-KO group saw an appreciable, 
though non-significant, decrease from the WT group. Interestingly, while not 
significant, Mk-801 seemed to increase the number of unsheathed PV cells in 
both WT and DISC1-KO groups. See figure 5 and figure 6.  
 
 
 Figure 5. A trending effect of gene on the number of vulnerable PV cells is 
observed in the superficial PL (# p = 0.072). DISC1-KO has a smaller number of 
PV cells without PNNs compared to WT when treated with saline. Likewise, 
DISC1-KO treated with MK-801 also had a smaller number of PV cells without 
PNN when compared to saline. MK-801 also seems to increase the number of 
unsheathed PV cells modestly.  
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Figure 6. Representative photomicrographs of sampled regions in the PL used 
for analysis of PV (red) and PNNs (green): superficial PL, deep PL and total 
(superficial + deep) PL. Total PL photos were captured at a lower magnification 
(10x) to fit the entire region in frame (A,D,G,J). MK-801 seems to increase, 
though not significantly, the number of unsheathed PV cells regardless of 
genotype. No appreciable differences were seen elsewhere in the PL.  
 
Infralimbic Cortex Findings 
  
Drug-induced changes in non-PNN surrounded PV cell counts in 
superficial, but not deep infralimbic layers. In the IL, there was a significant main 
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effect of treatment (saline vs. MK-801; F(1,29) = 5.054, p < 0.05) such that the 
number non-PNN sheathed PV cells showed a modest increase in MK-801 
groups, regardless of genotype. This main effect of drug treatment was observed 
only within the superficial layers of the IL. However, post-hoc multiple 
comparisons of the groups did not reveal any significant differences. See Figure 
7 for graphical data and Figure 8 for representative photomicrographs.  
 
 
 
Figure 7. A significant main effect of MK-801 treatment was seen within the 
superficial layers of the IL, evidenced by an increase in the mean number of PV 
cells without PNN ensheathment († p < 0.05). MK-801 treatment or genotype did 
not yield any significant differences in the number of ensheathed PV cells in the 
deep or total region of the IL.  
 
Treatment Effect on Vulnerable PV Cell Count in IL
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Figure 8. Representative overlaid (PV= red; PNNs = green) photomicrographs of 
IL regions that were analyzed: superficial IL, deep IL, and total IL (superficial and 
deep combined) in saline and MK-801 groups. Here, a modest increase in 
unsheathed PV cells in groups exposed to chronic MK-801 can be appreciated 
within the superficial IL, but not within the deep or total IL regions in both WT and 
DISC1 groups. 
 
PV cell count within the deep layers of appear to be mediated by a 
genotype by drug interaction. There was a trending Gene x Treatment interaction 
(F (1,28) = 3.022, p = 0.093). Though there were no significant differences in the 
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PV cell count between groups across the IL, there was an appreciable difference 
between WT/Saline and DISC1-KO/Saline groups in the deep layers. DISC1-
KO/Saline group saw a moderate decrease in PV cell count compared to WT 
counterparts. There were no significant differences seen between the groups in 
the total (p = 0.23) or superficial (p = 0.677) regions. See Figure 9 for graphical 
data and Figure 10 for representative photomicrographs of the regions of the IL.  
 
 
 
Figure 9. A trending interaction between treatment and genotype was observed 
in the deep layers of the IL. In saline treated groups, the DISC1-KO group saw a 
modest decrease in average count of PV cells compared to WT. Conversely, 
DISC1-KO group treated with MK-801 saw an appreciable increase in average 
count compared to saline. The decrease in DISC1-KO/Saline group appears to 
be driving the interaction effect seen. No other appreciable or significant 
differences were seen in the total or superficial regions of the IL.  
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Figure 10. Representative photomicrographs of sampled regions in the IL that 
were analyzed: superficial IL, deep IL, and total (superficial and deep combined) 
IL in saline and MK-801 groups. There was a modest, though non-significant 
decrease in the average number of PV cells in the deep IL in DISC1-KO group 
compared to WT when treated with saline. There was a modest increase in PV 
count in the DISC1-KO group when treated with MK-801 compared to saline. No 
significant differences were observed across all groups in superficial or total IL.  
 
Genotype-driven decrease in the % of PV cells surrounded by PNNs in 
deep layers of the IL. There was a trend towards a main effect of gene (F (1, 27) 
= 3.939, p = 0.057) evidenced by a noticeable decrease in the % of PV cells 
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surrounded by PNNs in the DISC1-KO/saline group compared to the WT/saline 
group. No additional notable changes were observed elsewhere in the IL. See 
figure 11 for graphical data and figure 12 for representative photomicrographs of 
IL regions.  
 
 
 
Figure 11. There is a trending, though not significant, effect of gene knockout on 
the % of PV cells surrounded by/colocalized with PNNs in the deep IL († = 
0.057). WT group saw a greater % of PV surrounded with PNN than DISC1-KO 
group. The DISC1-KO group treated with MK-801 appears to show an increase 
in the % of PV colocalized with PNN when viewed against DISC1-KO group that 
was treated with saline. Similar percentages of PV with PNNs are seen in the 
WT/Saline and DISC1-KO/MK-801. No other significant or discernable 
differences were detected in any of the groups across both total and superficial 
IL.  
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Figure 12. Representative photomicrographs of sampled regions in IL used for 
analysis: superficial IL, deep IL, and total (superficial and deep combined) IL. 
There was a trending decrease in the percentage of PV surrounded by PNN in 
DISC1-KO compared to WT regardless of treatment in the deep IL. A noticeable 
but nonsignificant increase in DISC1-KO was noticed when given MK-801 
treatment compared to saline.   
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DISCUSSION 
 The present study investigated the neuroanatomical consequences of a 
complete knock out of the DISC1 gene in male rats on changes in the 
characteristics/relationship of PV containing neurons and PNNs. This work 
further expanded on what is known regarding this particular risk gene by 
additionally employing a diathesis-stress model of schizophrenia, with the DISC1 
genetic predisposition compounded by a later adult NMDA antagonist challenge 
through both acute and sub-chronic administration of MK-801 (S. R. Jones & 
Fernyhough, 2007). Specifically, we looked for any genotype-dependent and/or 
drug treatment-dependent effects on the PV cell and PNN populations within the 
prefrontal cortex of rats. We observed that a knockout of DISC1 modestly 
decreases the number of PV cells and PNNs in saline control groups, while 
treatment with MK-801 had regionally- and layer-specific effects on PV and 
PNNs. Importantly, this work is the first to characterize neural changes 
associated with this novel DISC1 rat knockout model, and the results closely 
mirror those seen in postmortem schizophrenic prefrontal cortex (Lewis et al., 
2005).While the present results are trending in nature, they provide exciting 
evidence for a likely role of DISC1 in the contributions to the well-described 
changes seen in human PV and PNN changes in schizophrenic patient 
populations.  
 
 
	43 
Regionally-Specific Effects of DISC1-KO in Rat Prefrontal Cortex 
DISC1-KO lead to a modest decrease in the average number of PV cells 
compared to WT rats within the deep layers of the IL, a finding that is in general 
agreement with previous findings in other DISC1 condition and partial knock-
down rodent models (Ibi et al., 2010; Niwa et al., 2010; Umeda et al., 2016). The 
observed modest reduction in average PV cell count may be due to a decrease 
in protein expression and/or intensity, possibly leading to PV levels being difficult 
to detected in cells that may actually contain sub-threshold levels of PV protein. 
This interpretation is consistent with  postmortem findings in the PFC of 
schizophrenic patients (Takanori Hashimoto et al., 2003; Lewis et al., 2005; Volk 
et al., 2000; Woo, Kim, & Viscidi, 2008), in that there is a selective decrease in 
both GAD67 expression specific to PV expressing neurons (Akbarian et al., 
1995; Volk et al., 2000) and PV expression in schizophrenia (Lewis et al., 2005; 
Zhang & Reynolds, 2002) . Additionally, the DISC1-KO rats in this study 
exhibited a decreased number of PNNs in the PL compared to WT.  These 
results are comparable to recent work describing a decreased labeling intensity 
of PNNs seen in schizophrenic postmortem tissue samples (Enwright et al., 
2016; Mauney et al., 2013; Pantazopoulos et al., 2010). Since we did not 
specifically evaluate the staining intensity or mRNA levels in our present 
samples, we can reasonably assume that the decrease seen may be due to an 
inability to detect PNNs under 40x magnification due to the decreased protein 
expression. Differences in PNN count previously seen under low magnification 
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were eliminated when looking under a higher magnification and higher brightness 
index (Enwright et al., 2016).  
MK-801 Decreases PNNs, and Leads to an Increase in PV Expressing Cells. 
Here, we observed that MK-801 administration modestly increased the 
average number of PV cells that are not surrounded by PNNs in the superficial 
layers of both the IL and the PL. It is unclear if this increase is reflecting an 
overall decrease in PNNs, in PV cells, or a combination of both. However, we 
also saw that MK-801 treatment moderately decreased the number of PNNs in 
the PL of WT rats, suggesting that NMDA antagonist treatment might primarily 
affect PNNs, which supports previous findings of a reduction of PNN colocalized 
PV cells and reduction of cells that are positive for PNNs (Matuszko, Curreli, 
Kaushik, Becker, & Dityatev, 2017). This also replicates what has been seen in 
postmortem schizophrenic brains, in which there was a reduction of PNNs 
surrounding interneurons in the mPFC (Mauney et al., 2013). The regionally-
dependent effects are in line with the postmortem findings of decreased densities 
of PNNs largely specific to layer 3, which is considered a superficial layer 
(Mauney et al., 2013). Interestingly, MK-801 seemed to increase the number of 
PV cells in the deep IL, which was contradictory to our initial hypothesis that a 
two-hit (gene + later NMDA antagonist challenge) would lead to an exaggerated 
decrease in PV cells comparable to that seen in postmortem human patient 
populations. Despite this observation, these findings are highly consistent with 
previous findings from our group describing an age-dependent increases in PV 
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following chronic ketamine administration. Indeed, prior work has characterized a 
decrease in PV cell count when ketamine  was administered at a young age, with 
a concomitant increase when administered in adulthood (Abdul-Monim, Neill, & 
Reynolds, 2007; Honeycutt & Chrobak, 2018; Sabbagh et al., 2013). In the 
present study, all rats received their first injection of MK-801 in early adulthood at 
P45, and received chronic administrations starting at P100, which is well into 
adulthood, therefore making it very plausible that the increases described herein 
are likely driven by the age at which the MK-801 was administered.  
Functional consequences of increasing trend of unsheathed PV cells. 
 We observed trends of increased number of unsheathed PV cells with 
MK-801 treatment in the superficial layers of both IL and PL compared to saline. 
The lack of PNNs surrounding the PV cells suggests these cells are vulnerable to 
damage, which can lead to abnormalities or decreases in PV cells. This is 
consistent with previous evidence of PNN disruption resulting in a decrease in 
PV expression (Yamada, Ohgomori, & Jinno, 2015). The implications of 
decreased PV interneurons could be cortical dysfunction due to the role of PV in 
generating gamma frequency oscillations. This gamma oscillatory activity has 
been found to be critical in synchronizing cortical activity during cognitive tasks 
(Volman, Behrens, & Sejnowski, 2011). Therefore, abnormal oscillatory activity 
secondary to PV dysfunction may translate into impaired executive function 
capabilities that has been characterized frequently in schizophrenia.  
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There were a number of limitations in this study as the rats were sacrificed 
at a very old age, introducing potential age-related changes that could confound 
the results. Likewise, the rats utilized in the present work had undergone 
extensive behavioral training throughout their life, which has been noted to 
increase PV expression, and could strengthen the synapses (Patz, Grabert, 
Gorba, Wirth, & Wahle, 2004). These confounding factors could muddle the 
interpretations and potentially be the reason why we did not see many robust 
changes.  Future work should aim to elucidate these findings in the absence of 
these extraneous variables in order to isolate the differential effects of DISC1-KO 
genotype and MK-801 treatment on both neural and behavioral outcomes.  
Despite the limitations, there were some distinct advantages to the design 
of this study. While there are other studies that have measured the changes in 
PV utilizing a DISC1 model, this is the first rat model of schizophrenia with a full 
knock out of DISC1 in addition to an NMDA antagonist (MK-801) treatment 
challenge in adulthood. A full knock out allows a clearer interpretation of the 
relationship between DISC1 and the abnormalities seen in schizophrenia. This 
model reduces the ambiguity inherent in knockdown and/or transient disruption 
models where location of the changes may confer differential results which may 
not translate readily to patient populations. Furthermore, this is the first model to 
our knowledge that also looked at the relationship between DISC1 and 
alterations in the expression of PNNs. This model allowed us to address the 
decreases in PNNs seen in post mortem brains of schizophrenia and further 
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elucidate if the dysfunction may be driven by DISC1 in a novel and effective 
manner.  
Future directions would be to look at the neuroanatomical changes of a 
DISC1-KO rat model in the hippocampus, as this gene is highly expressed in this 
brain region (Austin, Ky, Ma, Morris, & Shughrue, 2004; Ma et al., 2002). Since 
decreases in hippocampal PV expression has been well-established in 
schizophrenic postmortem brain tissue, it is likely that more robust effects of the 
knockout will be observed here (Konradi et al., 2011; Torrey et al., 2005; Zhang 
& Reynolds, 2002). Indeed, the hippocampal findings in schizophrenia research 
are replicated more consistently compared to the prefrontal cortex (Lieberman et 
al., 2018). Therefore, such findings may provide greater evidence that supports 
the use of a full knockout of DISC1 as a translational rat model of schizophrenic 
neural and behavioral deficits.  To determine if a second insult is required (as 
proposed in the diathesis-stress model of schizophrenia), future studies should 
administer the NMDA antagonist treatment during adolescence, since psychosis 
typically emerges during early adulthood and this period has been shown to be 
particularly vulnerable to insult (Gomes, Rincón-Cortés, & Grace, 2016).  
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